Literature DB >> 33988700

Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countries.

Fabiola Valvert1, Oscar Silva2, Elizabeth Solórzano-Ortiz1, Maneka Puligandla3, Marcos Mauricio Siliézar Tala1, Timothy Guyon4, Samuel L Dixon4, Nelly López1, Francisco López1, César Camilo Carías Alvarado1, Robert Terbrueggen4, Kristen E Stevenson3, Yasodha Natkunam2, David M Weinstock5,6, Edward L Briercheck7.   

Abstract

Inadequate diagnostics compromise cancer care across lower- and middle-income countries (LMICs). We hypothesized that an inexpensive gene expression assay using paraffin-embedded biopsy specimens from LMICs could distinguish lymphoma subtypes without pathologist input. We reviewed all biopsy specimens obtained at the Instituto de Cancerología y Hospital Dr. Bernardo Del Valle in Guatemala City between 2006 and 2018 for suspicion of lymphoma. Diagnoses were established based on the World Health Organization classification and then binned into 9 categories: nonmalignant, aggressive B-cell, diffuse large B-cell, follicular, Hodgkin, mantle cell, marginal zone, natural killer/T-cell, or mature T-cell lymphoma. We established a chemical ligation probe-based assay (CLPA) that quantifies expression of 37 genes by capillary electrophoresis with reagent/consumable cost of approximately $10/sample. To assign bins based on gene expression, 13 models were evaluated as candidate base learners, and class probabilities from each model were then used as predictors in an extreme gradient boosting super learner. Cases with call probabilities < 60% were classified as indeterminate. Four (2%) of 194 biopsy specimens in storage <3 years experienced assay failure. Diagnostic samples were divided into 70% (n = 397) training and 30% (n = 163) validation cohorts. Overall accuracy for the validation cohort was 86% (95% confidence interval [CI]: 80%-91%). After excluding 28 (17%) indeterminate calls, accuracy increased to 94% (95% CI: 89%-97%). Concordance was 97% for a set of high-probability calls (n = 37) assayed by CLPA in both the United States and Guatemala. Accuracy for a cohort of relapsed/refractory biopsy specimens (n = 39) was 79% and 88%, respectively, after excluding indeterminate cases. Machine-learning analysis of gene expression accurately classifies paraffin-embedded lymphoma biopsy specimens and could transform diagnosis in LMICs.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2021        PMID: 33988700      PMCID: PMC8152509          DOI: 10.1182/bloodadvances.2021004347

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  26 in total

1.  Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.

Authors:  Javeed Iqbal; George Wright; Chao Wang; Andreas Rosenwald; Randy D Gascoyne; Dennis D Weisenburger; Timothy C Greiner; Lynette Smith; Shuangping Guo; Ryan A Wilcox; Bin Tean Teh; Soon Thye Lim; Soon Yong Tan; Lisa M Rimsza; Elaine S Jaffe; Elias Campo; Antonio Martinez; Jan Delabie; Rita M Braziel; James R Cook; Raymond R Tubbs; German Ott; Eva Geissinger; Philippe Gaulard; Pier Paolo Piccaluga; Stefano A Pileri; Wing Y Au; Shigeo Nakamura; Masao Seto; Francoise Berger; Laurence de Leval; Joseph M Connors; James Armitage; Julie Vose; Wing C Chan; Louis M Staudt
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

2.  NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.

Authors:  Steven M Horwitz; Stephen M Ansell; Weiyun Z Ai; Jeffrey Barnes; Stefan K Barta; Michael Choi; Mark W Clemens; Ahmet Dogan; John P Greer; Ahmad Halwani; Bradley M Haverkos; Richard T Hoppe; Eric Jacobsen; Deepa Jagadeesh; Youn H Kim; Matthew A Lunning; Amitkumar Mehta; Neha Mehta-Shah; Yahurio Oki; Elise A Olsen; Barbara Pro; Saurabh A Rajguru; Satish Shanbhag; Andrei Shustov; Lubomir Sokol; Pallawi Torka; Ryan Wilcox; Basem William; Jasmine Zain; Mary A Dwyer; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2018-02       Impact factor: 11.908

Review 3.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

4.  Evaluation of a panel of expert pathologists: review of the diagnosis and histological classification of Hodgkin and non-Hodgkin lymphomas in a population-based cancer registry.

Authors:  Leonie Strobbe; Saskia A M van der Schans; Sanneke Heijker; Jos W R Meijer; E J M Vera Mattijssen; Carolien M P W Mandigers; Ineke M de Kievit; John M M Raemaekers; Konnie M Hebeda; J Han J M van Krieken
Journal:  Leuk Lymphoma       Date:  2013-09-10

5.  Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.

Authors:  Camille Laurent; Marine Baron; Nadia Amara; Corinne Haioun; Mylène Dandoit; Marc Maynadié; Marie Parrens; Beatrice Vergier; Christiane Copie-Bergman; Bettina Fabiani; Alexandra Traverse-Glehen; Nicole Brousse; Marie-Christine Copin; Patrick Tas; Tony Petrella; Marie-Christine Rousselet; Josette Brière; Fréderic Charlotte; Catherine Chassagne-Clement; Thérèse Rousset; Luc Xerri; Anne Moreau; Antoine Martin; Diane Damotte; Peggy Dartigues; Isabelle Soubeyran; Michel Peoch; Pierre Dechelotte; Jean-François Michiels; Antoine de Mascarel; Françoise Berger; Céline Bossard; Flavie Arbion; Isabelle Quintin-Roué; Jean-Michel Picquenot; Martine Patey; Blandine Fabre; Henri Sevestre; Cécile Le Naoures; Marie-Pierre Chenard-Neu; Claire Bastien; Sylvie Thiebault; Laurent Martin; Manuela Delage; Thomas Filleron; Gilles Salles; Thierry Jo Molina; Georges Delsol; Pierre Brousset; Philippe Gaulard
Journal:  J Clin Oncol       Date:  2017-05-01       Impact factor: 44.544

Review 6.  Cancer Care and Control as a Human Right: Recognizing Global Oncology as an Academic Field.

Authors:  Alexandru E Eniu; Yehoda M Martei; Edward L Trimble; Lawrence N Shulman
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

Review 7.  Structural Barriers to Diagnosis and Treatment of Cancer in Low- and Middle-Income Countries: The Urgent Need for Scaling Up.

Authors:  Eduardo Cazap; Ian Magrath; T Peter Kingham; Ahmed Elzawawy
Journal:  J Clin Oncol       Date:  2015-11-17       Impact factor: 44.544

8.  Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.

Authors:  Anja Mottok; George Wright; Andreas Rosenwald; German Ott; Colleen Ramsower; Elias Campo; Rita M Braziel; Jan Delabie; Dennis D Weisenburger; Joo Y Song; Wing C Chan; James R Cook; Kai Fu; Tim Greiner; Erlend Smeland; Harald Holte; Kerry J Savage; Betty J Glinsmann-Gibson; Randy D Gascoyne; Louis M Staudt; Elaine S Jaffe; Joseph M Connors; David W Scott; Christian Steidl; Lisa M Rimsza
Journal:  Blood       Date:  2018-09-26       Impact factor: 25.476

9.  The Stanford Tissue Microarray Database.

Authors:  Robert J Marinelli; Kelli Montgomery; Chih Long Liu; Nigam H Shah; Wijan Prapong; Michael Nitzberg; Zachariah K Zachariah; Gavin J Sherlock; Yasodha Natkunam; Robert B West; Matt van de Rijn; Patrick O Brown; Catherine A Ball
Journal:  Nucleic Acids Res       Date:  2007-11-07       Impact factor: 16.971

10.  Discrepancies in Lymphoma Diagnosis Over the Years: A 13-Year Experience in a Tertiary Center.

Authors:  Neval Özkaya; Nuray Başsüllü; Ahu Senem Demiröz; Nükhet Tüzüner
Journal:  Turk J Haematol       Date:  2016-12-12       Impact factor: 1.831

View more
  3 in total

1.  Leveraging fine-needle aspiration to improve HIV-associated lymphoma diagnostic capacity in resource-limited settings.

Authors:  Kathryn Lurain; Thomas S Uldrick; José-Tomás Navarro
Journal:  AIDS       Date:  2022-08-01       Impact factor: 4.632

Review 2.  Precision Medicine in Low- and Middle-Income Countries.

Authors:  Jerald P Radich; Edward Briercheck; Daniel T Chiu; Manoj P Menon; Olga Sala Torra; Cecilia C S Yeung; Edus H Warren
Journal:  Annu Rev Pathol       Date:  2022-01-24       Impact factor: 32.350

3.  Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA Sequencing.

Authors:  Jeremy Wang; Nickhill Bhakta; Vanessa Ayer Miller; Mahler Revsine; Mark R Litzow; Elisabeth Paietta; Yuri Fedoriw; Kathryn G Roberts; Zhaohui Gu; Charles G Mullighan; Corbin D Jones; Thomas B Alexander
Journal:  JCO Precis Oncol       Date:  2022-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.